B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors

Expression of V(D)J recombinase activity in developing lymphocytes is absolutely required for initiation of V(D)J recombination at antigen receptor loci. However, little is known about when during hematopoietic development the V(D)J recombinase is first active, nor is it known what elements activate...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of experimental medicine Vol. 199; no. 4; pp. 491 - 502
Main Authors: Borghesi, Lisa, Hsu, Lih-Yun, Miller, Juli P, Anderson, Michael, Herzenberg, Leonard, Herzenberg, Leonore, Schlissel, Mark S, Allman, David, Gerstein, Rachel M
Format: Journal Article
Language:English
Published: United States The Rockefeller University Press 16-02-2004
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Expression of V(D)J recombinase activity in developing lymphocytes is absolutely required for initiation of V(D)J recombination at antigen receptor loci. However, little is known about when during hematopoietic development the V(D)J recombinase is first active, nor is it known what elements activate the recombinase in multipotent hematopoietic progenitors. Using mice that express a fluorescent transgenic V(D)J recombination reporter, we show that the V(D)J recombinase is active as early as common lymphoid progenitors (CLPs) but not in the upstream progenitors that retain myeloid lineage potential. Evidence of this recombinase activity is detectable in all four progeny lineages (B, T, and NK, and DC), and rag2 levels are the highest in progenitor subsets immediately downstream of the CLP. By single cell PCR, we demonstrate that V(D)J rearrangements are detectable at IgH loci in approximately 5% of splenic natural killer cells. Finally, we show that recombinase activity in CLPs is largely controlled by the Erag enhancer. As activity of the Erag enhancer is restricted to the B cell lineage, this provides the first molecular evidence for establishment of a lineage-specific transcription program in multipotent progenitors.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Abbreviations used in this paper: CJ, coding joint; CLP, common lymphoid progenitor; ETP, early thymic T lineage progenitor; RAG, recombinase-activating gene; RSS, recombination signal sequence; SJ, signal joint.
Address correspondence to Rachel M. Gerstein, Molecular Genetics and Microbiology, University of Massachusetts Medical School, 55 Lake Ave. North, S5-714, Worcester, MA 01655. Phone: (508) 856-1044; Fax: (508) 856 5920; email: rachel.gerstein@umassmed.edu
The online version of this article contains supplemental material.
Dr. Michael Anderson died on September 20, 2002.
ISSN:0022-1007
1540-9538
DOI:10.1084/jem.20031800